DEEPCAUSALAI
DEAD

Serial Number

98855929

Owner

Prescriptive Genomics, Inc

Attorney

Susan M Ference

Filing Date

Nov 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DEEPCAUSALAI Trademark

Serial Number: 98855929

DEEPCAUSALAI is a trademark filed by Prescriptive Genomics, Inc on November 15, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Prescriptive Genomics, Inc

48651 Beaver Creek Drive
Plymouth Township, MI 48170

Entity Type: 03

Trademark Details

Filing Date

November 15, 2024

Registration Date

Not Registered

Published for Opposition

June 24, 2025

Goods & Services

Financial analysis, namely, compiling and analyzing statistics, data and other sources of information for financial purposes; Financial data analysis; Financial risk assessment services; Financial advisory and consultancy services, namely, compiling and analyzing statistics, data and other sources of information for financial purposes; Financial advisory and consultancy services, namely, in the area of healthcare

Computer software design; Developing computer software; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug discovery and development; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for therapeutic drug selection and optimization; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for predicting drug effectiveness, interactions and side effects; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug design; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for generating personal patient treatment plans based on predictive analytics; Software authoring; Software design and development

Downloadable computer software for producing financial models; Downloadable computer software using artificial intelligence (AI) for drug discovery and development; Downloadable computer software using artificial intelligence (AI) for therapeutic drug selection and optimization; Downloadable computer software using artificial intelligence (AI) for predicting drug effectiveness, interactions and side effects; Downloadable computer software using artificial intelligence (AI) for therapeutic target selection and optimization; Downloadable computer software using artificial intelligence (AI) for drug design; Downloadable computer software using artificial intelligence (AI) for collecting, analyzing and organizing data in the field of deep learning; Downloadable computer software using artificial intelligence (AI) for generating personal patient treatment plans based on predictive analytics; Downloadable computer software using artificial intelligence (AI) for patient management, treatment, risk assessment and selection of specific interventions

Analyzing and compiling business data for making predictions based on data inputs; Business data analysis; Business research and data analysis services in the field of patient treatment managment; Compiling and analyzing statistics, data and other sources of information for business purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 23, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 23, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 19, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 24, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 24, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 20, 2025 CNSA
ASSIGNED TO EXAMINER
May 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
NEW APPLICATION ENTERED
Nov 15, 2024 NWAP